$35 million more for device center
This article was originally published in The Silver Sheet
Executive Summary
CDRH would receive a $35 million increase for center and field activities under a fiscal year 2010 funding measure approved June 11 by the House Agriculture, Rural Development, FDA and Related Agencies Appropriations Subcommittee. This accords with the 12.5 percent increase over FY 2009 funding that President Obama requested for the device center in his FY 2010 budget proposal to Congress ("The Silver Sheet" May 2009). Subcommittee Chairwoman Rosa DeLauro, D-Conn., says the investment will "help reform and significantly improve" how FDA ensures medical product safety. The funding boost would bring appropriations for CDRH to $315 million in FY 2010; user fees from industry would provide an additional $56 million to the center's budget. Overall, the subcommittee approved $2.35 billion for FDA for the next fiscal year - an increase of $298.6 million above FY 2009 funding levels
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.